June 11, 2018 – Washington, DC – On Friday, June 8, 2018, The New York Times published an editorial titled “Easier Drug Approval Isn’t Cutting Drug Prices.” In it, The Times Editorial Board claims the FDA is lowering standards by working to get treatments to patients more quickly and instituting a “less regulation” approach to…
“Cancer patients cannot afford logistical delays and the OCE was not established to add another layer of bureaucracy.” – Ellen Sigal Washington, DC – March 14, 2018 – On Thursday, March 15, 2018, the U.S. Food and Drug Administration (FDA) will hold a public listening session on the Oncology Center of Excellence (OCE) from 9am…
WASHINGTON, DC, November 13, 2017 – Today, President Trump nominated Alex Azar to be the next Health and Human Services (HHS) Secretary. As the former head of one of our nation’s largest employers, Azar understands the multifaceted challenges that a Secretary may face. He previously served as Deputy HHS Secretary and HHS Chief Counsel under…
Friends Applauds Senate for FDA User Fee Bill Passage; Urges President Trump to Quickly Sign Into Law Washington, DC – August 3, 2017 – Friends of Cancer Research (Friends) applauds the Senate for voting overwhelmingly (94-1) today to pass the FDA Reauthorization Act of 2017 (H.R. 2430). The bill will now go to President Trump…
Friends of Cancer Research Applauds This Nomination Washington, DC – June 14, 2017 – President Donald Trump has nominated Dr. Norman E. Sharpless to be the next director at the National Cancer Institute (NCI). He will be replacing acting director Dr. Doug Lowy at the largest division within the National Institutes of Health. “We would…
Amendment Provides Opportunity for Patients to More Easily Gain Access to Potentially Beneficial Experimental Therapies While in Development Friends of Cancer Research (Friends) would like to thank and applaud the work of Senators Orrin Hatch (R-UT), Michael Bennet (D-CO), Richard Burr (R-NC), and Bob Casey (D-PA) who once again showed their tireless commitment to patients…
Washington, DC, April 27, 2017 – Friends of Cancer Research (Friends) would like to thank Chairman Alexander and the Senate HELP Committee for voting to report Dr. Scott Gottlieb’s nomination to be FDA commissioner favorably to the full Senate for a vote. The committee vote was 14-9 in favor of moving the nomination forward. …
Washington, DC, April 20, 2017 – Friends of Cancer Research (Friends) Chairperson & Founder, Ellen V. Sigal, will receive the Face of Hope award at LUNGevity’s Celebration of Hope event tomorrow evening. The Face of Hope award is presented to an individual who recognizes the needs of those living with lung cancer and is actively…
Today, at 10am ET, Dr. Scott Gottlieb, the President’s nominee for FDA Commissioner, will appear before the Senate Health, Education, Labor and Pensions (HELP) Committee for his confirmation hearing. We will be live-tweeting the hearing: Follow us on Twitter for the latest Senate HELP will also be broadcasting the hearing via webcast The Advocacy…
Washington, DC, March 27, 2017 – Today, Friends of Cancer Research (Friends) launched a new online learning community, ProgressForPatients.org. The site is home to two new programs Friends has been developing over the course of the last year, Friends’ Advocacy Education and Advocacy Alliance. “We set out to create an online community, a place where…
